Teens with kidney disease get a fitness boost in new study
NCT ID NCT06624358
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a 12-week physical activity program can help teens aged 13–18 with chronic kidney disease (stages II–V) become more active. Participants will wear a Fitbit to track their moderate-to-vigorous exercise. The goal is to see if the program increases daily activity and improves quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- behavioral intervention to increase physical activity
- What this could lead to
- If it works, this could show that a simple exercise program helps teens with kidney disease become more active and feel better.
- What could go wrong
- This is a small, early-stage study with only 64 teens, so results may not apply to everyone. The program is short (12 weeks), and long-term benefits are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
13 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: For adolescent participants: 1. Males or females age 13 - 18 years 2. Diagnosis of CKD stage II - V not yet on dialysis or with a transplant 3. English proficiency 4. Parental/guardian permission (informed consent), and if applicable, child assent For caregiver participants: 1. Parent/legal guardian of an enrolled adolescent participant 2. English proficiency Exclusion Criteria: For adolescent participants: 1. Pregnant or lactating 2. Non-ambulatory 3. Have high physical activity at baseline (\>45 min/day of MVPA) 4. Provide \<2 days of physical activity data during the run-in period 5. Have a condition, such as heart or lung disease, that preclude safely engaging in physical activity 6. Have received a solid organ transplant 7. Have limited English proficiency 8. Are on dialysis 9. In the opinion of the investigator, are unable to comply with the requirements of the study protocol or are unsuitable for the study for any reason For caregivers participants: 1\. Limited English proficiency
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Does better dialysis keep parathyroid hormone in check?
- Biobank aims to unlock the mysteries of calciphylaxis
- Do kidney patients know why a fistula matters before dialysis?
- Potassium binder may let kidney patients keep Life-Saving heart drugs